124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
Clinical trial NCT01583842 · TERMINATED
Trial details
- NCT number
- NCT01583842
- Sponsor
- Miguel Pampaloni
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-09
- Primary completion
- 2021-02-25
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.